Fesarius Therapeutics

Fesarius Therapeutics is a bioregenerative surgical company specializing in advanced dermal tissue regeneration solutions. The company develops innovative hydrogel-based scaffold technology for treating full-thickness skin loss resulting from burns, trauma, plastic surgery, and tumor removal. Fesarius's flagship product, DermiSphere™ hDRT, is a dual-density collagen hydrogel dermal regeneration template featuring a unique microarchitecture that supports rapid cellular invasion and vascularization. The template maintains ideal wound bed conditions while facilitating stable tissue regeneration, achieving 100% wound bed incorporation by Day 3 and full vascularization by Day 7 in pre-clinical studies. Designed for ease of clinical use with omnidirectional application, conformability to irregular wound topographies, and in-situ trimming capability, DermiSphere addresses the unmet need for effective dermal reconstruction in wound care and reconstructive surgery applications.